Carotid Artery DiseasesBAROXNCT03493971
Hemodynamics and Autonomic and Cognitive Performance After Carotid Revascularization Procedures
A study testing Carotid revascularization performed using CAS and Carotid revascularization performed using CEA in people with Carotid Artery Diseases, run by Ospedale San Donato at 1 site in Italy.
Trial summary
Carotid revascularization procedures are performed for more than 87% of cases in patients with asymptomatic internal carotid stenosis (ICS), who are assumed to have a life expectancy of at least 5 years. Read more about this study
- Who is it for?
- Ages 18 to 75 years
- Conditions the study is for
- Carotid Artery Diseases
- What is being tested?
- Carotid revascularization performed using CAS and Carotid revascularization performed using CEA
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 70 participants
- Where
- 1 siteItaly
- Study dates
- 21 Mar 2018to 29 Nov 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 75 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Informed consent signed
- Patients with >=70% symptomatic or >=80% asymptomatic internal carotid stenosis
Who cannot join
- Incapability to give informed consent
- Previous disabling stroke
- Contralateral carotid occlusion or >70% stenosis
- Systemic disease judged non compatible with the procedures or randomization
- Suspected or manifested pregnancy
- General contraindications to MRI or CT studies
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Impact of Carotid Endarterectomy and Stenting on Hemodynamics, Fluid-structure Interaction, Autonomic Modulation, and Cognitive Brain Function
Carotid revascularization procedures are performed for more than 87% of cases in patients with asymptomatic internal carotid stenosis (ICS), who are assumed to have a life expectancy of at least 5 years. Hence, the investigators aim to compare carotid artery stenting (CAS) with carotid endarterectomy (CEA) in terms of long-term prognostic endpoints in patients with uneventful perioperative course. CEA and CAS, as a consequence of either surgical trauma or mechanical stimuli related to the compliance mismatch between the stented segment and the native artery, may perturb carotid baroreceptors function causing an impairment of cardiovascular autonomic control. Also, CEA and CAS result in different postoperative geometric features of carotid arteries that entail relevant modifications of rheological parameters, that may be associated with the risk of local complications. Finally, long-term and sustained cognitive benefits after CAS as compared to CEA are yet to be demonstrated.
Read the detailed description
Hypothesis and Significance: Late clinical outcome and prognosis after CAS may be inferior to that after CEA in terms of autonomic modulation, hemodynamic remodeling, and cognitive function.
Specific Aim: 1) To compare the impact of CEA and CAS on long-term post-operative baroreceptor function and on cognitive brain function, and analyze their influence on clinical outcome. The specific goal is to assess the potential correlation between post-operative autonomic and cognitive function. 2) To assess the solicitation on the carotid wall due to CAS as compared to CEA through structural analysis and mechanical modeling. The specific goal is to assess the potential correlation between stenting, wall damage, baroceptor impairment, and late neurological sequelae. 3) To assess the post-operative carotid hemodynamics combining medical image analysis, clinical data, and computer simulations. The specific goal aims at correlating both local (e.g., wall stress stress) and global phenomena (controlateral flow, arterial stiffening) with baroreflex function and post-operative neurological outcomes.
Experimental Design Aim 1: A computerized method requiring small operator interaction will be used to assess indices of autonomic sympathovagal balance directed to the sinoatrial node, sympathetic vasomotor modulation, and baroreflex gain, all from spontaneous beat-by-beat variations of the R-R interval and systolic arterial pressure (SAP) variability, considering only sinus rhythm conditions. After electrode and sensor positioning, patients will be maintained for 10 minute in resting supine position, necessary for stabilization, subsequently blood pressure waveforms, electrocardiogram and respiratory activity will be continuously recorded during a nominal 5-minute baseline and then for subsequent 5-minute period of active standing.
Cardiovascular signals will be acquired by a 4 channel digital polygraph. The electrocardiogram will be recorded with two electrodes placed on the patient's chest, breathing pattern will be recorded by a piezoelectric belt and finger arterial blood pressure will be continuously monitored by a CNAP 500 HD continuous noninvasive hemodynamics monitor (CNSystems Medizintechnik AG, Austria). As described previously, (8) a series of indexes indirectly reflecting autonomic cardiovascular modulation will be derived from the spectral analysis of R-R interval and SAP variability. Postoperative cardiovascular autonomic control will be correlated to clinical outcome and measures of cognitive performance. Enrolled patients will be submitted to Mini-Mental State Examination for general cognitive impairment screening. Cognitive P300 evoked potentials will be then recorded, before and after treatment, with Ag/AgCl electrodes with a Brain Vision Recorder (Brain Products GmbH, Gilching, Germany). P300 evoked potentials will be generated after a binaurally presented tone discrimination paradigm (odd-ball paradigm) with frequent (80%) tones of 1000 Hz and rare (20%) target tones of 2000 Hz at 75 dB HL. Filter bandpass will be 0.01 to 30 Hz. Active electrodes will be placed at Cz (vertex) and Fz (frontal), respectively, and referenced to linked earlobe A1/2 electrodes (10/20 international system). During the paradigm, the patients will be instructed to keep a running mental count of the rare 2000-Hz target tones. To verify attention, P300 recordings with a discrepancy of>10% between the actual number of stimuli and the number counted by the patients will be rejected and repeated. P300 evoked potential recording will result in a stable sequence of positive and negative peaks. Latencies in milliseconds (ms) of the cognitive P300 peak will be assessed. To confirm reproducibility, two sets of P300 measurements will be recorded for all patients.
Experimental Design Aim 2: The computer-based simulation of CAS is performed exploiting a computational framework, which can be used to analyze both stent apposition and vessel wall stress in a virtual manner. The framework accounts for two main parts: the vessel model and stent model. Preoperative and postoperative medical images (including high resolution Contrast Enhanced (CE)-MRI and Computed Tomography Angiography (CTA)) will represent the input to build a patient specific carotid model. The 3D lumen profile of the vessel is reconstructed through the segmentation of DICOM image stack using tools like ITK-SNAP (www.itksnap.org) or VMTK (www.vmtk.org). The computational domain (the so-called mesh), used to solve the equilibrium equations governing the structural stent-vessel interaction, is created by an in-house developed procedure, coded in Matlab (The Mathworks Inc., Natick,MA, USA). The non-linear mechanical response of the arterial tissue is reproduced adopting an anisotropic hyperelastic strain-energy function, accounting for two families of fibers, oriented along a preferred direction with a certain degree of dispersion. The model parameters will be calibrated with respect to experimental tensile tests of the carotid tissue. The arterial model is then assembled in the simulation environment with a given stent model, picked from a predefined library of stent designs (the stent mesh generation is based on geometrical measurements performed on high-resolution micro-CT of stent samples). The CAS simulation is performed through structural finite element analysis (FEA); the commercial FEA solver Abaqus (Simulia, Dassault Systemes, FR), is adopted to run the simulations. The engineering outcomes of the simulations, (i.e. the nodal displacement field, stress tensor and strain at each integration points of the mesh), are elaborated to assess clinically relevant parameters of stenting performance (e.g. lumen gain, vessel straightening, stent cell size). The output will be used as an input of the Computational Fluid Dynamics analysis to evaluate the impact of the implanted design on the local haemodynamics (e.g., wall shear stress, oscillatory shear index, etc). Similarly, the structural analysis of CEA will be performed through the virtual pressurization of the post-operative arterial geometry.
Experimental design 3: Moving from Computational Fluid Dynamics and Fluid-Structure Interaction analysis, the investigators plan to introduce a specific model to describe the baroreflex function and this may be affected by the two different types of treatment (CEA and CAS). This requires the set up of a so-called "geometrical multiscale" model. With this, the investigators mean a numerical model coupling a local description of the hemodynamics (the one developed in Aim 2) with a more systemic representation. The latter consists of two components:
- a 1D network mathematically described by a system of partial differential equations representing the propagation of the pressure wave along the arterial tree; each segment of the network is given by a hyperbolic system called "Euler equations" b) a compartment model for representing the peripheral microcirculation and for including the feedback mechanisms induced by the baroreflex function. Following, this will be represented by a system of ordinary differential equations where resistances properly depend on the baroreflex function.
In this aim the investigators plan two sub-aims:
- Set up of a computational multiscale model within the framework of the LifeV solver, a finite element general purpose C++ Object Oriented library, developed by A. Veneziani and his collaborators (in Milan Politecnico and Lausanne EPFL) www.lifev.org and openly downloadable. At this stage, the investigators will reproduce the general model of Blanco et al. In particular, the identification of the parameters for the two different levels of models (1D and Lumped Parameters) will be carried out following the procedure suggested. Validation of the solver will also take advantage of the benchmarks presented in this paper.
- Adoption of the solver previously developed for the test cases considered in Aim 2. This means that the 3D model developed in Aim 2 will be adopted for the 3D part of the geometrical multiscale model. This will allow to provide a quantitative analysis of the different impact of the two treatments and ultimately to assess in a virtual scenario how the changes of carotid compliance may impair the baroreflex function. All the CAS and CEA cases considered in Aim 2 will be equipped of this multiscale framework. The expected deliverables of this aim are therefore: a) a validated open source geometrical multiscale solver including the baroreflex function to be used systematically in patient-specific settings. b) extensive comparison of the performances of the different options.
- Conditions
- Carotid Artery Diseases
- Being tested
- Carotid revascularization performed using CAS, Carotid revascularization performed using CEA
- Keywords
- carotid endarterectomy, carotid stenting, autonomic function, computational fluid dynamic, cognitive function
- Medical subject headings
- Carotid Artery Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Carotid revascularization performed using CASProcedure or surgery
Carotid artery stenting (CAS) is an endovascular stent procedure used to treat narrowing of the carotid artery and decrease the risk of stroke
Carotid revascularization performed using CEAProcedure or surgery
Carotid endarterectomy (CEA) is a surgical procedure used to correct stenosis in the common carotid artery or internal carotid artery and reduce the risk of stroke
| Study group | Role | What they receive |
|---|---|---|
| Carotid artery stenting (CAS) | Active comparator | Carotid revascularization performed using CAS Receives: Procedure: Carotid revascularization performed using CAS |
| Carotid endarterectomy (CEA) | Active comparator | Carotid revascularization performed using CEA Receives: Procedure: Carotid revascularization performed using CEA |
What is being measured
The primary outcome is the main question the study is designed to answer.
R-R interval (sec) and Systolic Arterial Pressure (SAP) (mmHg) in rest and tilt position for baroreceptor function
Comparison pre- and post-CAS, Comparison pre- and post-CEA
Measured: 20 months
Secondary outcomes (12)
Cognitive P300 latency (ms)
Comparison pre- and post-CAS, Comparison pre- and post-CEA
Measured: 20 months
Mean and maximum flow velocity magnitude (cm/sec) in common carotid artery (CCA) and internal carotid artery (ICA) along the cardiac cycle
Comparison pre- and post-CAS, Comparison pre- and post-CEA
Measured: 20 months
Systolic wall shear stress (dyn/cm2)
Comparison pre- and post-CAS, Comparison pre- and post-CEA
Measured: 20 months
Time-averaged wall shear stress (TAWSS) (dyn/cm2)
Comparison pre- and post-CAS, Comparison pre- and post-CEA
Measured: 20 months
Oscillatory index (OSI) (%)
Comparison pre- and post-CAS, Comparison pre- and post-CEA
Measured: 20 months
Flow helicity (-)
Comparison pre- and post-CAS, Comparison pre- and post-CEA
Measured: 20 months
CCA/ICA Flow split (%)
Comparison pre- and post-CAS, Comparison pre- and post-CEA
Measured: 20 months
Common carotid artery (CCA) - internal carotid artery (ICA) mean and maximum pressure drop (mmHg)
Comparison pre- and post-CAS, Comparison pre- and post-CEA
Measured: 20 months
Carotid wall von Mises stress (dyn/cm2) at the systolic peak
Comparison pre- and post-CAS, Comparison pre- and post-CEA
Measured: 20 months
Carotid wall maximum principal stress (dyn/cm2) at the systolic peak and corresponding directions (-) Maximum, mean, and min principal strain (-) and corresponding directions (-)
Comparison pre- and post-CAS, Comparison pre- and post-CEA
Measured: 20 months
Carotid augmentation index (%) of pressure wave
Comparison pre- and post-CAS, Comparison pre- and post-CEA
Measured: 20 months
Effective reflecting distance (mm) of pressure wave
Comparison pre- and post-CAS, Comparison pre- and post-CEA
Measured: 20 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Apr 2018
- Study start21 Mar 2018
- Primary completion20 Apr 2022
- Study completion29 Nov 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (17)Papers the sponsor has linked to this study.
- Other trials for Carotid Artery DiseasesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 70 participants (actual)
Sponsor and investigators
- Lead sponsor
- Ospedale San Donato
- Sponsor type
- University, hospital or other
- Collaborators
- Emory University, University of Pavia
- Responsible party
- Principal investigator, Massimiliano M. Marrocco-Trischitta, Ospedale San Donato
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03493971
- Sponsor's protocol ID
- 62/int/2017
- Other IDs
- PE-2013-02355484
- Acronym
- BAROX
- Status last verified
- Nov 2023
- First submitted
- 5 Dec 2017
- Last updated
- 30 Nov 2023
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Cutlip DE, Pinto DS. Extracranial carotid disease revascularization. Circulation. 2012 Nov 27;126(22):2636-44. doi: 10.1161/CIRCULATIONAHA.112.110411. No abstract available.
PubMed 23184283Marrocco-Trischitta MM, Cremona G, Lucini D, Natali-Sora MG, Cursi M, Cianflone D, Pagani M, Chiesa R. Peripheral baroreflex and chemoreflex function after eversion carotid endarterectomy. J Vasc Surg. 2013 Jul;58(1):136-44.e1. doi: 10.1016/j.jvs.2012.11.130. Epub 2013 Apr 28.
PubMed 23632295Hayase H, Tokunaga K, Nakayama T, Sugiu K, Nishida A, Arimitsu S, Hishikawa T, Ono S, Ohta M, Date I. Computational fluid dynamics of carotid arteries after carotid endarterectomy or carotid artery stenting based on postoperative patient-specific computed tomography angiography and ultrasound flow data. Neurosurgery. 2011 Apr;68(4):1096-101; discussion 1101. doi: 10.1227/NEU.0b013e318208f1a0.
PubMed 21221041Irvine CD, Gardner FV, Davies AH, Lamont PM. Cognitive testing in patients undergoing carotid endarterectomy. Eur J Vasc Endovasc Surg. 1998 Mar;15(3):195-204. doi: 10.1016/s1078-5884(98)80176-7.
PubMed 9587331Bohm M, Cotton D, Foster L, Custodis F, Laufs U, Sacco R, Bath PM, Yusuf S, Diener HC. Impact of resting heart rate on mortality, disability and cognitive decline in patients after ischaemic stroke. Eur Heart J. 2012 Nov;33(22):2804-12. doi: 10.1093/eurheartj/ehs250. Epub 2012 Aug 26.
PubMed 22922507Davies PF. Overview: temporal and spatial relationships in shear stress-mediated endothelial signalling. J Vasc Res. 1997 May-Jun;34(3):208-11. doi: 10.1159/000159224. No abstract available.
PubMed 9226302Hathcock JJ. Flow effects on coagulation and thrombosis. Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):1729-37. doi: 10.1161/01.ATV.0000229658.76797.30. Epub 2006 Jun 1.
PubMed 16741150Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P, Sandrone G, Malfatto G, Dell'Orto S, Piccaluga E, et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res. 1986 Aug;59(2):178-93. doi: 10.1161/01.res.59.2.178.
PubMed 2874900Auricchio F, Conti M, De Beule M, De Santis G, Verhegghe B. Carotid artery stenting simulation: from patient-specific images to finite element analysis. Med Eng Phys. 2011 Apr;33(3):281-9. doi: 10.1016/j.medengphy.2010.10.011. Epub 2010 Nov 9.
PubMed 21067964Conti M, Van Loo D, Auricchio F, De Beule M, De Santis G, Verhegghe B, Pirrelli S, Odero A. Impact of carotid stent cell design on vessel scaffolding: a case study comparing experimental investigation and numerical simulations. J Endovasc Ther. 2011 Jun;18(3):397-406. doi: 10.1583/10-3338.1.
PubMed 21679082Auricchio F, Conti M, Ferrara A, Morganti S, Reali A. Patient-specific finite element analysis of carotid artery stenting: a focus on vessel modeling. Int J Numer Method Biomed Eng. 2013 Jun;29(6):645-64. doi: 10.1002/cnm.2511. Epub 2012 Sep 29.
PubMed 23729192Auricchio F, Conti M, Ferraro M, Reali A. Evaluation of carotid stent scaffolding through patient-specific finite element analysis. Int J Numer Method Biomed Eng. 2012 Oct;28(10):1043-55. doi: 10.1002/cnm.2509. Epub 2012 Aug 25.
PubMed 23027634De Santis G, Conti M, Trachet B, De Schryver T, De Beule M, Degroote J, Vierendeels J, Auricchio F, Segers P, Verdonck P, Verhegghe B. Haemodynamic impact of stent-vessel (mal)apposition following carotid artery stenting: mind the gaps! Comput Methods Biomech Biomed Engin. 2013;16(6):648-59. doi: 10.1080/10255842.2011.629997. Epub 2011 Dec 8.
PubMed 22149183De Santis G, Trachet B, Conti M, De Beule M, Morbiducci U, Mortier P, Segers P, Verdonck P, Verhegghe B. A computational study of the hemodynamic impact of open- versus closed-cell stent design in carotid artery stenting. Artif Organs. 2013 Jul;37(7):E96-106. doi: 10.1111/aor.12046. Epub 2013 Apr 12.
PubMed 23578331Blanco PJ, Trenhago PR, Fernandes LG, Feijoo RA. On the integration of the baroreflex control mechanism in a heterogeneous model of the cardiovascular system. Int J Numer Method Biomed Eng. 2012 Apr;28(4):412-33. doi: 10.1002/cnm.1474. Epub 2011 Nov 2.
PubMed 25365656
Study at a glance
From the registry record, last updated by the sponsor on 30 Nov 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Impact of Carotid Endarterectomy and Stenting on Hemodynamics, Fluid-structure Interaction, Autonomic Modulation, and Cognitive Brain Function
- ClinicalTrials.gov ID
- NCT03493971
- Acronym / sponsor ID
- BAROX / 62/int/2017
- Conditions
- Carotid Artery Diseases
- Keywords
- carotid endarterectomy, carotid stenting, autonomic function, computational fluid dynamic, cognitive function
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 70 participants (actual)
- Lead sponsor
- Ospedale San DonatoUniversity, hospital or other
- Collaborators
- Emory University, University of Pavia
- Study start
- 21 Mar 2018 (actual)
- Primary completion
- 20 Apr 2022 (actual)
- Study completion
- 29 Nov 2023 (actual)
- First posted
- 11 Apr 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Carotid revascularization procedures are performed for more than 87% of cases in patients with asymptomatic internal carotid stenosis (ICS), who are assumed to have a life expectancy of at least 5 years. Hence, the investigators aim to compare carotid artery stenting (CAS) with carotid endarterectomy (CEA) in terms of long-term prognostic endpoints in patients with uneventful perioperative course. CEA and CAS, as a consequence of either surgical trauma or mechanical stimuli related to the compliance mismatch between the stented segment and the native artery, may perturb carotid baroreceptors function causing an impairment of cardiovascular autonomic control. Also, CEA and CAS result in different postoperative geometric features of carotid arteries that entail relevant modifications of rheological parameters, that may be associated with the risk of local complications. Finally, long-term and sustained cognitive benefits after CAS as compared to CEA are yet to be demonstrated.
Detailed description
Hypothesis and Significance: Late clinical outcome and prognosis after CAS may be inferior to that after CEA in terms of autonomic modulation, hemodynamic remodeling, and cognitive function.
Specific Aim: 1) To compare the impact of CEA and CAS on long-term post-operative baroreceptor function and on cognitive brain function, and analyze their influence on clinical outcome. The specific goal is to assess the potential correlation between post-operative autonomic and cognitive function. 2) To assess the solicitation on the carotid wall due to CAS as compared to CEA through structural analysis and mechanical modeling. The specific goal is to assess the potential correlation between stenting, wall damage, baroceptor impairment, and late neurological sequelae. 3) To assess the post-operative carotid hemodynamics combining medical image analysis, clinical data, and computer simulations. The specific goal aims at correlating both local (e.g., wall stress stress) and global phenomena (controlateral flow, arterial stiffening) with baroreflex function and post-operative neurological outcomes.
Experimental Design Aim 1: A computerized method requiring small operator interaction will be used to assess indices of autonomic sympathovagal balance directed to the sinoatrial node, sympathetic vasomotor modulation, and baroreflex gain, all from spontaneous beat-by-beat variations of the R-R interval and systolic arterial pressure (SAP) variability, considering only sinus rhythm conditions. After electrode and sensor positioning, patients will be maintained for 10 minute in resting supine position, necessary for stabilization, subsequently blood pressure waveforms, electrocardiogram and respiratory activity will be continuously recorded during a nominal 5-minute baseline and then for subsequent 5-minute period of active standing.
Cardiovascular signals will be acquired by a 4 channel digital polygraph. The electrocardiogram will be recorded with two electrodes placed on the patient's chest, breathing pattern will be recorded by a piezoelectric belt and finger arterial blood pressure will be continuously monitored by a CNAP 500 HD continuous noninvasive hemodynamics monitor (CNSystems Medizintechnik AG, Austria). As described previously, (8) a series of indexes indirectly reflecting autonomic cardiovascular modulation will be derived from the spectral analysis of R-R interval and SAP variability. Postoperative cardiovascular autonomic control will be correlated to clinical outcome and measures of cognitive performance. Enrolled patients will be submitted to Mini-Mental State Examination for general cognitive impairment screening. Cognitive P300 evoked potentials will be then recorded, before and after treatment, with Ag/AgCl electrodes with a Brain Vision Recorder (Brain Products GmbH, Gilching, Germany). P300 evoked potentials will be generated after a binaurally presented tone discrimination paradigm (odd-ball paradigm) with frequent (80%) tones of 1000 Hz and rare (20%) target tones of 2000 Hz at 75 dB HL. Filter bandpass will be 0.01 to 30 Hz. Active electrodes will be placed at Cz (vertex) and Fz (frontal), respectively, and referenced to linked earlobe A1/2 electrodes (10/20 international system). During the paradigm, the patients will be instructed to keep a running mental count of the rare 2000-Hz target tones. To verify attention, P300 recordings with a discrepancy of>10% between the actual number of stimuli and the number counted by the patients will be rejected and repeated. P300 evoked potential recording will result in a stable sequence of positive and negative peaks. Latencies in milliseconds (ms) of the cognitive P300 peak will be assessed. To confirm reproducibility, two sets of P300 measurements will be recorded for all patients.
Experimental Design Aim 2: The computer-based simulation of CAS is performed exploiting a computational framework, which can be used to analyze both stent apposition and vessel wall stress in a virtual manner. The framework accounts for two main parts: the vessel model and stent model. Preoperative and postoperative medical images (including high resolution Contrast Enhanced (CE)-MRI and Computed Tomography Angiography (CTA)) will represent the input to build a patient specific carotid model. The 3D lumen profile of the vessel is reconstructed through the segmentation of DICOM image stack using tools like ITK-SNAP (www.itksnap.org) or VMTK (www.vmtk.org). The computational domain (the so-called mesh), used to solve the equilibrium equations governing the structural stent-vessel interaction, is created by an in-house developed procedure, coded in Matlab (The Mathworks Inc., Natick,MA, USA). The non-linear mechanical response of the arterial tissue is reproduced adopting an anisotropic hyperelastic strain-energy function, accounting for two families of fibers, oriented along a preferred direction with a certain degree of dispersion. The model parameters will be calibrated with respect to experimental tensile tests of the carotid tissue. The arterial model is then assembled in the simulation environment with a given stent model, picked from a predefined library of stent designs (the stent mesh generation is based on geometrical measurements performed on high-resolution micro-CT of stent samples). The CAS simulation is performed through structural finite element analysis (FEA); the commercial FEA solver Abaqus (Simulia, Dassault Systemes, FR), is adopted to run the simulations. The engineering outcomes of the simulations, (i.e. the nodal displacement field, stress tensor and strain at each integration points of the mesh), are elaborated to assess clinically relevant parameters of stenting performance (e.g. lumen gain, vessel straightening, stent cell size). The output will be used as an input of the Computational Fluid Dynamics analysis to evaluate the impact of the implanted design on the local haemodynamics (e.g., wall shear stress, oscillatory shear index, etc). Similarly, the structural analysis of CEA will be performed through the virtual pressurization of the post-operative arterial geometry.
Experimental design 3: Moving from Computational Fluid Dynamics and Fluid-Structure Interaction analysis, the investigators plan to introduce a specific model to describe the baroreflex function and this may be affected by the two different types of treatment (CEA and CAS). This requires the set up of a so-called "geometrical multiscale" model. With this, the investigators mean a numerical model coupling a local description of the hemodynamics (the one developed in Aim 2) with a more systemic representation. The latter consists of two components:
- a 1D network mathematically described by a system of partial differential equations representing the propagation of the pressure wave along the arterial tree; each segment of the network is given by a hyperbolic system called "Euler equations" b) a compartment model for representing the peripheral microcirculation and for including the feedback mechanisms induced by the baroreflex function. Following, this will be represented by a system of ordinary differential equations where resistances properly depend on the baroreflex function.
In this aim the investigators plan two sub-aims:
- Set up of a computational multiscale model within the framework of the LifeV solver, a finite element general purpose C++ Object Oriented library, developed by A. Veneziani and his collaborators (in Milan Politecnico and Lausanne EPFL) www.lifev.org and openly downloadable. At this stage, the investigators will reproduce the general model of Blanco et al. In particular, the identification of the parameters for the two different levels of models (1D and Lumped Parameters) will be carried out following the procedure suggested. Validation of the solver will also take advantage of the benchmarks presented in this paper.
- Adoption of the solver previously developed for the test cases considered in Aim 2. This means that the 3D model developed in Aim 2 will be adopted for the 3D part of the geometrical multiscale model. This will allow to provide a quantitative analysis of the different impact of the two treatments and ultimately to assess in a virtual scenario how the changes of carotid compliance may impair the baroreflex function. All the CAS and CEA cases considered in Aim 2 will be equipped of this multiscale framework. The expected deliverables of this aim are therefore: a) a validated open source geometrical multiscale solver including the baroreflex function to be used systematically in patient-specific settings. b) extensive comparison of the performances of the different options.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Carotid artery stenting (CAS) | Active comparator | Procedure: Carotid revascularization performed using CASCarotid revascularization performed using CAS |
| Carotid endarterectomy (CEA) | Active comparator | Procedure: Carotid revascularization performed using CEACarotid revascularization performed using CEA |
Who may qualify
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Informed consent signed
- Patients with >=70% symptomatic or >=80% asymptomatic internal carotid stenosis
Key exclusion criteria (6 listed)
- Incapability to give informed consent
- Previous disabling stroke
- Contralateral carotid occlusion or >70% stenosis
- Systemic disease judged non compatible with the procedures or randomization
- Suspected or manifested pregnancy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Carotid revascularization performed using CASCarotid artery stenting (CAS) is an endovascular stent procedure used to treat narrowing of the carotid artery and decrease the risk of stroke | Procedure or surgery | Carotid artery stenting (CAS) |
| Carotid revascularization performed using CEACarotid endarterectomy (CEA) is a surgical procedure used to correct stenosis in the common carotid artery or internal carotid artery and reduce the risk of stroke | Procedure or surgery | Carotid endarterectomy (CEA) |
Primary outcome
R-R interval (sec) and Systolic Arterial Pressure (SAP) (mmHg) in rest and tilt position for baroreceptor function
Time frame: 20 months
Comparison pre- and post-CAS, Comparison pre- and post-CEA
12 secondary outcomes
Cognitive P300 latency (ms)
Time frame: 20 months
Mean and maximum flow velocity magnitude (cm/sec) in common carotid artery (CCA) and internal carotid artery (ICA) along the cardiac cycle
Time frame: 20 months
Systolic wall shear stress (dyn/cm2)
Time frame: 20 months
Time-averaged wall shear stress (TAWSS) (dyn/cm2)
Time frame: 20 months
Oscillatory index (OSI) (%)
Time frame: 20 months
Flow helicity (-)
Time frame: 20 months
CCA/ICA Flow split (%)
Time frame: 20 months
Common carotid artery (CCA) - internal carotid artery (ICA) mean and maximum pressure drop (mmHg)
Time frame: 20 months
Carotid wall von Mises stress (dyn/cm2) at the systolic peak
Time frame: 20 months
Carotid wall maximum principal stress (dyn/cm2) at the systolic peak and corresponding directions (-) Maximum, mean, and min principal strain (-) and corresponding directions (-)
Time frame: 20 months
Carotid augmentation index (%) of pressure wave
Time frame: 20 months
Effective reflecting distance (mm) of pressure wave
Time frame: 20 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Nov 2023.
- Background: PubMed 23184283Cutlip DE, Pinto DS. Extracranial carotid disease revascularization. Circulation. 2012 Nov 27;126(22):2636-44. doi: 10.1161/CIRCULATIONAHA.112.110411. No abstract available.
- Background: PubMed 23632295Marrocco-Trischitta MM, Cremona G, Lucini D, Natali-Sora MG, Cursi M, Cianflone D, Pagani M, Chiesa R. Peripheral baroreflex and chemoreflex function after eversion carotid endarterectomy. J Vasc Surg. 2013 Jul;58(1):136-44.e1. doi: 10.1016/j.jvs.2012.11.130. Epub 2013 Apr 28.
- Background: PubMed 21221041Hayase H, Tokunaga K, Nakayama T, Sugiu K, Nishida A, Arimitsu S, Hishikawa T, Ono S, Ohta M, Date I. Computational fluid dynamics of carotid arteries after carotid endarterectomy or carotid artery stenting based on postoperative patient-specific computed tomography angiography and ultrasound flow data. Neurosurgery. 2011 Apr;68(4):1096-101; discussion 1101. doi: 10.1227/NEU.0b013e318208f1a0.
- Background: PubMed 9587331Irvine CD, Gardner FV, Davies AH, Lamont PM. Cognitive testing in patients undergoing carotid endarterectomy. Eur J Vasc Endovasc Surg. 1998 Mar;15(3):195-204. doi: 10.1016/s1078-5884(98)80176-7.
- Background: PubMed 22922507Bohm M, Cotton D, Foster L, Custodis F, Laufs U, Sacco R, Bath PM, Yusuf S, Diener HC. Impact of resting heart rate on mortality, disability and cognitive decline in patients after ischaemic stroke. Eur Heart J. 2012 Nov;33(22):2804-12. doi: 10.1093/eurheartj/ehs250. Epub 2012 Aug 26.
- Background: PubMed 9226302Davies PF. Overview: temporal and spatial relationships in shear stress-mediated endothelial signalling. J Vasc Res. 1997 May-Jun;34(3):208-11. doi: 10.1159/000159224. No abstract available.
- Background: PubMed 16741150Hathcock JJ. Flow effects on coagulation and thrombosis. Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):1729-37. doi: 10.1161/01.ATV.0000229658.76797.30. Epub 2006 Jun 1.
- Background: PubMed 2874900Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P, Sandrone G, Malfatto G, Dell'Orto S, Piccaluga E, et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res. 1986 Aug;59(2):178-93. doi: 10.1161/01.res.59.2.178.
- Background: PubMed 21067964Auricchio F, Conti M, De Beule M, De Santis G, Verhegghe B. Carotid artery stenting simulation: from patient-specific images to finite element analysis. Med Eng Phys. 2011 Apr;33(3):281-9. doi: 10.1016/j.medengphy.2010.10.011. Epub 2010 Nov 9.
- Background: PubMed 21679082Conti M, Van Loo D, Auricchio F, De Beule M, De Santis G, Verhegghe B, Pirrelli S, Odero A. Impact of carotid stent cell design on vessel scaffolding: a case study comparing experimental investigation and numerical simulations. J Endovasc Ther. 2011 Jun;18(3):397-406. doi: 10.1583/10-3338.1.
- Background: PubMed 23729192Auricchio F, Conti M, Ferrara A, Morganti S, Reali A. Patient-specific finite element analysis of carotid artery stenting: a focus on vessel modeling. Int J Numer Method Biomed Eng. 2013 Jun;29(6):645-64. doi: 10.1002/cnm.2511. Epub 2012 Sep 29.
- Background: PubMed 23027634Auricchio F, Conti M, Ferraro M, Reali A. Evaluation of carotid stent scaffolding through patient-specific finite element analysis. Int J Numer Method Biomed Eng. 2012 Oct;28(10):1043-55. doi: 10.1002/cnm.2509. Epub 2012 Aug 25.
- Individual participant dataSharing planned: No
Related trials for Carotid Artery Diseases
Not yet recruitingObservational study
CAROTID DOPPLER AND CEREBRAL OXIMERY IN POST CARDIAC ARREST ICU PATIENTS
Cardiac Arrest (CA), Carotid Doppler
Active, not recruitingObservational study
Symptomatic Carotid Outcomes Registry
Carotid Stenosis, Ischemic Stroke
RecruitingObservational study
Estimated Risk of Preeclampsia in the First Trimester and Its Association With Subclinical Atherosclerosis and Cardiovascular Risk in Women With Type 1 Diabetes
Type 1 Diabetes, Preeclampsia
Not yet recruitingObservational study
PET-MR Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis With 64Cu-NODAGA-CANF (Multisite)
Carotid Atherosclerosis, Carotid Artery Stenosis Asymptomatic
Not yet recruiting
UltraTrac for Cardiac Output Monitoring in Congenital Heart Disease
Congenital Heart Disease, Cardiac Output
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Carotid revascularization performed using CAS and Carotid revascularization performed using CEA in people with Carotid Artery Diseases, run by Ospedale San Donato at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 30 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
R-R interval (sec) and Systolic Arterial Pressure (SAP) (mmHg) in rest and tilt position for baroreceptor function (time frame: 20 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03493971, which also lists 17 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Nov 2023.